Camber Capital Management as of Sept. 30, 2018
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 26 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 24.9 | $581M | 2.0M | 290.72 | |
| Allergan | 7.3 | $171M | 900k | 190.48 | |
| Hca Holdings (HCA) | 6.0 | $139M | 1.0M | 139.12 | |
| Mylan Nv | 5.9 | $137M | 3.8M | 36.60 | |
| Tesaro | 5.8 | $137M | 3.5M | 39.01 | |
| Universal Health Services (UHS) | 4.9 | $115M | 900k | 127.84 | |
| Biogen Idec (BIIB) | 4.5 | $106M | 300k | 353.31 | |
| McKesson Corporation (MCK) | 4.3 | $100M | 750k | 132.65 | |
| Nektar Therapeutics (NKTR) | 3.9 | $91M | 1.5M | 60.96 | |
| Global Blood Therapeutics In | 3.4 | $79M | 2.1M | 38.00 | |
| Momenta Pharmaceuticals | 3.2 | $76M | 2.9M | 26.30 | |
| Perrigo Company (PRGO) | 3.0 | $71M | 1.0M | 70.80 | |
| Atara Biotherapeutics | 2.9 | $67M | 1.6M | 41.35 | |
| Brookdale Senior Living (BKD) | 2.7 | $64M | 6.5M | 9.83 | |
| Envision Healthcare | 2.6 | $62M | 1.4M | 45.73 | |
| Medicines Company | 2.6 | $60M | 2.0M | 29.91 | |
| AMAG Pharmaceuticals | 2.3 | $53M | 2.7M | 20.00 | |
| Clovis Oncology | 2.2 | $51M | 1.8M | 29.37 | |
| Tenet Healthcare Corporation (THC) | 1.9 | $44M | 1.6M | 28.46 | |
| Puma Biotechnology (PBYI) | 1.5 | $34M | 750k | 45.85 | |
| K2m Group Holdings | 1.2 | $27M | 1.0M | 27.37 | |
| Zymeworks | 0.9 | $22M | 1.4M | 15.70 | |
| Eagle Pharmaceuticals (EGRX) | 0.9 | $20M | 292k | 69.33 | |
| Endologix | 0.8 | $18M | 9.3M | 1.91 | |
| Sutro Biopharma (STRO) | 0.4 | $9.0M | 600k | 15.00 | |
| Surgery Partners (SGRY) | 0.1 | $2.2M | 135k | 16.50 |
